Cargando…

Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers

INTRODUCTION: Autologous skin cell suspension (ASCS) significantly reduces donor skin requirements versus conventional split-thickness skin grafts (STSG) for thermal burn treatment. In analyses using the Burn-medical counter measure Effectiveness Assessment Cost Outcomes Nexus (BEACON) model, ASCS w...

Descripción completa

Detalles Bibliográficos
Autores principales: Carter, Jeffrey E., Carson, Joshua S., Hickerson, William L., Rae, Lisa, Saquib, Syed F., Wibbenmeyer, Lucy A., Becker, Russell V., Walsh, Thomas P., Sparks, Jeremiah A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472178/
https://www.ncbi.nlm.nih.gov/pubmed/36103088
http://dx.doi.org/10.1007/s12325-022-02306-y
_version_ 1784789249897267200
author Carter, Jeffrey E.
Carson, Joshua S.
Hickerson, William L.
Rae, Lisa
Saquib, Syed F.
Wibbenmeyer, Lucy A.
Becker, Russell V.
Walsh, Thomas P.
Sparks, Jeremiah A.
author_facet Carter, Jeffrey E.
Carson, Joshua S.
Hickerson, William L.
Rae, Lisa
Saquib, Syed F.
Wibbenmeyer, Lucy A.
Becker, Russell V.
Walsh, Thomas P.
Sparks, Jeremiah A.
author_sort Carter, Jeffrey E.
collection PubMed
description INTRODUCTION: Autologous skin cell suspension (ASCS) significantly reduces donor skin requirements versus conventional split-thickness skin grafts (STSG) for thermal burn treatment. In analyses using the Burn-medical counter measure Effectiveness Assessment Cost Outcomes Nexus (BEACON) model, ASCS was associated with shorter hospital length of stay (LOS) and cost savings versus STSG. This study hypothesized that daily practice data from the USA would support these findings. METHODS: Electronic medical record data from 500 healthcare facilities (January 2019–August 2020) were used to match adult patients who received inpatient burn treatment with ASCS (± STSG) to patients treated with STSG alone on the basis of sex, age, percent total body surface area (TBSA), and comorbidities. Based on BEACON analyses, LOS was assumed to represent 70% of total costs and used as a proxy to assess the data. Mean LOS, costs, and the incremental revenue associated with inpatient capacity changes were calculated. RESULTS: A total of 151 ASCS and 2443 STSG patients were identified: 63.0% were male and average age was 44.5 years. Eight-one matches were made between cohorts. LOS was 21.7 days with ASCS and 25.0 days with STSG alone (difference 3.3 days [13.2%]). LOS was lower with ASCS than STSG in four of five TBSA intervals. The LOS difference led to hospital bed cost savings of $25,864 per ASCS patient; overall cost savings were $36,949 per patient. Similar cost savings were observed in TBSA groupings < 20% and ≥ 20%. The reduced LOS with ASCS translated into an increased capacity of 2.2 inpatients/bed annually, which increased hospital revenue by $92,283/burn unit bed annually. CONCLUSIONS: Real-world data show that ASCS (± STSG) is associated with reduced LOS and cost savings versus STSG alone across all burn sizes, supporting the validity of the BEACON analyses. ASCS use may also increase patient capacity and throughput, leading to increased hospital revenue. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-022-02306-y.
format Online
Article
Text
id pubmed-9472178
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-94721782022-09-14 Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers Carter, Jeffrey E. Carson, Joshua S. Hickerson, William L. Rae, Lisa Saquib, Syed F. Wibbenmeyer, Lucy A. Becker, Russell V. Walsh, Thomas P. Sparks, Jeremiah A. Adv Ther Original Research INTRODUCTION: Autologous skin cell suspension (ASCS) significantly reduces donor skin requirements versus conventional split-thickness skin grafts (STSG) for thermal burn treatment. In analyses using the Burn-medical counter measure Effectiveness Assessment Cost Outcomes Nexus (BEACON) model, ASCS was associated with shorter hospital length of stay (LOS) and cost savings versus STSG. This study hypothesized that daily practice data from the USA would support these findings. METHODS: Electronic medical record data from 500 healthcare facilities (January 2019–August 2020) were used to match adult patients who received inpatient burn treatment with ASCS (± STSG) to patients treated with STSG alone on the basis of sex, age, percent total body surface area (TBSA), and comorbidities. Based on BEACON analyses, LOS was assumed to represent 70% of total costs and used as a proxy to assess the data. Mean LOS, costs, and the incremental revenue associated with inpatient capacity changes were calculated. RESULTS: A total of 151 ASCS and 2443 STSG patients were identified: 63.0% were male and average age was 44.5 years. Eight-one matches were made between cohorts. LOS was 21.7 days with ASCS and 25.0 days with STSG alone (difference 3.3 days [13.2%]). LOS was lower with ASCS than STSG in four of five TBSA intervals. The LOS difference led to hospital bed cost savings of $25,864 per ASCS patient; overall cost savings were $36,949 per patient. Similar cost savings were observed in TBSA groupings < 20% and ≥ 20%. The reduced LOS with ASCS translated into an increased capacity of 2.2 inpatients/bed annually, which increased hospital revenue by $92,283/burn unit bed annually. CONCLUSIONS: Real-world data show that ASCS (± STSG) is associated with reduced LOS and cost savings versus STSG alone across all burn sizes, supporting the validity of the BEACON analyses. ASCS use may also increase patient capacity and throughput, leading to increased hospital revenue. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-022-02306-y. Springer Healthcare 2022-09-14 2022 /pmc/articles/PMC9472178/ /pubmed/36103088 http://dx.doi.org/10.1007/s12325-022-02306-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Carter, Jeffrey E.
Carson, Joshua S.
Hickerson, William L.
Rae, Lisa
Saquib, Syed F.
Wibbenmeyer, Lucy A.
Becker, Russell V.
Walsh, Thomas P.
Sparks, Jeremiah A.
Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers
title Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers
title_full Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers
title_fullStr Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers
title_full_unstemmed Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers
title_short Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers
title_sort length of stay and costs with autologous skin cell suspension versus split-thickness skin grafts: burn care data from us centers
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472178/
https://www.ncbi.nlm.nih.gov/pubmed/36103088
http://dx.doi.org/10.1007/s12325-022-02306-y
work_keys_str_mv AT carterjeffreye lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters
AT carsonjoshuas lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters
AT hickersonwilliaml lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters
AT raelisa lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters
AT saquibsyedf lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters
AT wibbenmeyerlucya lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters
AT beckerrussellv lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters
AT walshthomasp lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters
AT sparksjeremiaha lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters